These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 7055808)
1. Protection of mice against lethal doses of 1 beta-D-arabinofuranosylcytosine by pluripotent stem cell inhibitors. Guigon M; Mary JY; Enouf J; Frindel E Cancer Res; 1982 Feb; 42(2):638-41. PubMed ID: 7055808 [TBL] [Abstract][Full Text] [Related]
2. Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment. Wdzieczak-Bakala J; Guigon M; Lenfant M; Frindel E Biomed Pharmacother; 1983; 37(9-10):467-71. PubMed ID: 6689548 [TBL] [Abstract][Full Text] [Related]
3. [Inhibitors of bone marrow stem cells proliferation. Possible applications during chemotherapy (author's transl)]. Guigon M; Frindel E Bull Cancer; 1981; 68(2):150-3. PubMed ID: 7236900 [TBL] [Abstract][Full Text] [Related]
4. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide. Paukovits WR; Guigon M; Binder KA; Hergl A; Laerum OD; Schulte-Hermann R Cancer Res; 1990 Jan; 50(2):328-32. PubMed ID: 2295072 [TBL] [Abstract][Full Text] [Related]
5. Increasing 1-beta-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics. Ubezio P; Tagliabue G; Schechter B; Agur Z Cancer Res; 1994 Dec; 54(24):6446-51. PubMed ID: 7987841 [TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
7. Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cells. Lopez M; Wdzieczak-Bakala J; Pradelles P; Frindel E Leukemia; 1991 Mar; 5(3):270-2. PubMed ID: 2013983 [TBL] [Abstract][Full Text] [Related]
8. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine. Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822 [TBL] [Abstract][Full Text] [Related]
9. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice. Drize N; Chertkov J; Samoilina N; Zander A Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232 [TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
11. Are stem cells exposed to ionizing radiation in vivo as effective as nonirradiated transfused stem cells in restoring hematopoiesis? Cronkite EP; Inoue T; Hirabayashi Y; Bullis J Exp Hematol; 1993 Jun; 21(6):823-5. PubMed ID: 8500580 [TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cells in the hereditarily anemic Belgrade laboratory (b/b) rat. Ivanović Z; Milenković P; Vasiljevska M; Dekić M Exp Hematol; 1995 Oct; 23(11):1218-23. PubMed ID: 7556533 [TBL] [Abstract][Full Text] [Related]
13. Drug sequence-dependent toxicity and small bowel mucosal injury in mice treated with low doses of 3-deazauridine and 1-beta-D-arabinofuranosylcytosine. Paterson AR; Jakobs ES; Lauzon GJ; Weinstein WM Cancer Res; 1979 Jun; 39(6 Pt 1):2216-9. PubMed ID: 445420 [TBL] [Abstract][Full Text] [Related]
14. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340 [TBL] [Abstract][Full Text] [Related]
15. Sources of haemopoietic stem cell proliferation: stimulators and inhibitors. Lord BI; Wright EG Blood Cells; 1980; 6(4):581-93. PubMed ID: 7470631 [TBL] [Abstract][Full Text] [Related]
16. Age-dependent abnormalities of hematopoietic stem cells in (NZW x BXSB)F1 mice. Sugihara A; Adachi Y; Inaba M; Hisha H; Sugiura K; Miyashima S; Amoh Y; Taketani S; Oyaizu H; Ikebukuro K; Kawamura M; Genba H; Horio T; Ikehara S Stem Cells; 1999; 17(6):357-65. PubMed ID: 10606164 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic manipulation of cytokines: transforming growth factor beta-1 protects mice treated with lethal doses of cytarabine. Pierce DF; Coffey RJ Am Surg; 1994 Jan; 60(1):18-25. PubMed ID: 8273969 [TBL] [Abstract][Full Text] [Related]
18. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radioresistant subfraction. Inoue T; Hirabayashi Y; Mitsui H; Sasaki H; Cronkite EP; Bullis JE; Bond VP; Yoshida K Exp Hematol; 1995 Nov; 23(12):1296-300. PubMed ID: 7589285 [TBL] [Abstract][Full Text] [Related]
19. Changes in stem cell compartments in CBA mice after treatment by serum obtained from leucophoretic rats. Stojanović NN; Jovcić GS; Hajduković SI; Milenković PB Cell Tissue Kinet; 1983 Jan; 16(1):93-8. PubMed ID: 6825160 [TBL] [Abstract][Full Text] [Related]
20. Changes of bone marrow stromal cells (MSC) in mice after drug induced eradication of hematopoietic cells: in vitro effects on normal bone marrow. Ben-Ishay Z; Prindull G; Sharon S Biomed Pharmacother; 1982; 36(8-9):353-9. PubMed ID: 7182013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]